Enhancement of Natural Killer Cell Cytotoxicity by Sodium/Iodide Symporter Gene-Mediated Radioiodine Pretreatment in Breast Cancer Cells

Quantitative Immunohistochemical Analysis Reveals Association between Sodium Iodide Symporter and Estrogen Receptor Expression in Breast Cancer

(2013) Sushmita Chatterjee et al.   PLoS One

Sodium Iodide Symporter for Nuclear Molecular Imaging and Gene Therapy: From Bedside to Bench and Back

(2012) Byeong-Cheol Ahn   Theranostics

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression

(2011) Xiulong Xu et al.   BMC CANCER

Breast cancer statistics, 2011

(2011) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Sodium Iodide Symporter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue

(2011) James Ryan et al.   PLoS One

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

(2010) N. Fortunati et al.   BREAST CANCER RESEARCH AND TREATMENT

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

(2010) Melissa A. Geller et al.   CYTOTHERAPY

Anti-neoplastic and immunostimulatory effects of low-dose X-ray fractions in mice

(2010) Ewa M. Nowosielska et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Human Sodium/Iodide Symporter-Mediated Radioiodine Gene Therapy Enhances the Killing Activities of CTLs in a Mouse Tumor Model

(2010) Y. H. Jeon et al.   MOLECULAR CANCER THERAPEUTICS

Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma

(2010) Yixiong Zhou et al.   Pigment Cell & Melanoma Research

Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition

(2009) E. Ames et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

(2009) T. Sutlu et al.   JOURNAL OF INTERNAL MEDICINE

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

(2008) A. Kruschinski et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA